Understanding TrumpRx: What EB Brokers Need to Know

# Understanding TrumpRx: What EB Brokers Need to Know

There's been a lot of conversation lately about changes in the Rx space — various states passing new legislation targeting PBM transparency, rebate pass-through requirements, and more. And now we have a new wrinkle: TrumpRx.

TrumpRx is the new federal direct-to-consumer drug pricing portal launching in 2026. For many employers, especially those running self-funded health plans, the natural question is: how does this actually affect our pharmacy strategy?

Here's a clear breakdown.

## What TrumpRx Is

TrumpRx is a government-run search portal (TrumpRx.gov) that helps consumers find discounted cash prices on certain brand-name medications by routing them directly to participating manufacturers' purchasing pages. It does not process claims, ship medications, or integrate with insurance.

Several major manufacturers — including Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, and others — have already agreed to offer select drugs at Most-Favored-Nation (MFN)-aligned pricing and significantly reduced cash costs through the portal.

## What This Means (and Doesn't Mean) for Your Plan

For self-funded employers, TrumpRx represents a parallel marketplace — not a replacement for the pharmacy benefit. That distinction is critical.

Members who use TrumpRx are paying cash, outside the plan. These purchases don't count toward deductibles or out-of-pocket maximums. The transactions bypass the PBM entirely, which means no rebates, no utilization data, and no formulary management.

For high-cost categories like GLP-1s, TrumpRx may offer lower cash prices that employees will compare against the plan's coverage. It can reduce plan spend if members voluntarily choose cash-pay instead of submitting claims — but that comes with real trade-offs in visibility and member experience.

## Where Brokers Should Focus

This is where your role matters. Employers are going to hear about TrumpRx and want to know what to do with it. The right answer depends on their plan design, their population, and their appetite for complexity. A few things worth walking through with your clients:

- Is TrumpRx something to communicate as an informational option, or is it better left alone for now?
- For high-deductible members struggling with brand-name costs, could cash-pay pricing through TrumpRx offer meaningful relief — even if it doesn't coordinate with the plan?
- What's the rebate trade-off if members start shifting volume to cash-pay channels?

While TrumpRx may evolve into something more integrated over time, today it's best understood as an optional cash-pay alternative — not a self-funded plan solution. We'll continue tracking its operational impact as details unfold.

## TrumpRx FAQs for Self-Funded Employers

**Does TrumpRx replace our pharmacy benefit or PBM contract?**
No. TrumpRx is not insurance and does not replace your plan, PBM relationship, or formulary. It's an optional cash-buy channel for members — nothing more.

**Can employees apply TrumpRx purchases to their deductible or out-of-pocket max?**
No. These transactions occur outside the plan and do not count toward deductible, OOP max, accumulator programs, or specialty benefit thresholds.

**Will TrumpRx reduce our pharmacy claim spend?**
Possibly. If a member pays cash via TrumpRx instead of using their insurance, that claim is removed from plan spend. However, this must be weighed against loss of rebate value, reduced visibility into utilization, and potential member confusion.

**Can we integrate TrumpRx into our plan design?**
Not currently. The program provides no mechanisms for benefit integration, claims feeds, safety monitoring, or eligibility confirmation. That may change, but nothing formal exists today.